MD Anderson Research Highlights: SITC 2022 Special Edition
November 10, 2022
November 10, 2022
HOUSTON, Texas, Nov. 10 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Featuring advances in treating HPV-positive head and neck cancers, new microbiome signatures linked to response, and encouraging data from novel immunotherapy drugs
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical c . . .
* * *
Featuring advances in treating HPV-positive head and neck cancers, new microbiome signatures linked to response, and encouraging data from novel immunotherapy drugs
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical c . . .